The Suitability of Sniff Dog as a Tool in Screening Tumors

Status Recruiting

Clinical Trial Summary

Previous studies have demonstrated that sniff dogs can identify cancer patients from healthy subjects through sniffing exhaled breath air or blood or serum or urine or feces. It is hypothesized that sniff dogs may be used as a tool in screening cancer patients in health examination. Trained dogs will sniff serum from participants who are attending the annual health examination to identify potential or high risk subjects, and the results will be compared with the outcome of the traditional health examination, and the high risk subjects will be followed periodically for at least five years.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02049645
Study type	Observational
Source	Central South University
Contact	Chang-Qing Gao, MD PhD
Phone	86 13974981039
Email	cgao851@126.com
Status	Recruiting
Phase
Start date	January 2014
Completion date	March 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00339989` - Cervical Cancer Early Endpoints and Determinants
Completed	`NCT01954836` - Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial	N/A
Not yet recruiting	`NCT03979014` - Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial	Phase 3
Completed	`NCT02065297` - Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Recruiting	`NCT02049658` - The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
Completed	`NCT01523912` - Radiofrequency Ablation for the Treatment of Gastric Dysplasia	Phase 4
Completed	`NCT03415126` - A Study of ASN007 in Patients With Advanced Solid Tumors	Phase 1
Enrolling by invitation	`NCT00792649` - Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy	N/A
Recruiting	`NCT05158712` - Genetic Factors and Pheochromocytomas in Neoplasia Type 2
Completed	`NCT01962103` - Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors	Phase 1/Phase 2
Terminated	`NCT01456143` - Optical Imaging of Head and Neck Cancer	N/A
Recruiting	`NCT04341181` - ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling	Phase 2
Recruiting	`NCT02925234` - The Drug Rediscovery Protocol (DRUP Trial)	Phase 2